Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

• Status: Completed
• Trial end date: 2007-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the safety and efficacy of bimatoprost in patients with glaucoma or ocular hypertension

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Bimatoprost

Criteria

Inclusion Criteria:

• Clinical diagnosis of glaucoma or ocular hypertension in both eyes

• Patient requires IOP-lowering drug in both eyes

Exclusion Criteria:

• Uncontrolled medical conditions

• Ocular seasonal allergies within the past 2 years